Administrative Judge Kevin Dougherty of the Philadelphia Court of Common Pleas has set up a mass tort docket for Xarelto cases. Judge Doughertyreportedly ordered that 75 cases be transferred to the special Xarelto docket. The court’s order comes in response to predictions by lawyers representing Xarelto victims that thousands of lawsuits will be filed across the country.
Xarelto is a blood thinning drug developed to prevent strokes, deep vein thrombosis and pulmonary embolism in patients who suffer from atrial fibrillation. The drug, manufactured and marketed by Bayer Healthcare Pharmaceuticals and Janssen Pharmaceuticals, was approved by the FDA in July 2011.
Drugmakers intended Xarelto to replace Warfarin, the blood thinner of choice for atrial fibrillation patients for more than 50 years. Following a robust marketing campaign by Bayer and Janssen, global sales of Xarelto went from $582 million in 2011 to $2 billion in 2013.
In the first year after the drug’s approval, however, the FDA received more than 1,000 Xarelto-related adverse events, including 65 deaths. The problem, according to lawyers representing those whose loved ones died after taking the drug, is that Xarelto causes an increased risk of uncontrollable serious bleeding with no available reversal agent.
Waters Kraus & Paul: Learn More about Filing a Xarelto Lawsuit
Waters Kraus & Paul is a national plaintiffs’ law firm devoted to helping families in personal injury and wrongful death cases involving Xarelto blood thinning drugs as well as other dangerous pharmaceuticals and drug injuries. Based in Dallas, Texas, with offices in California and Maryland, Waters Kraus & Paul has participated in the representation of families from all fifty states and many foreign countries, as well as foreign governments.
If you have suffered injuries or the death of a loved one associated with Xarelto,contact us or call our Xarelto attorneys at 800.226.9880 to learn more about how we can assist you with a Xarelto lawsuit.